Last Updated: June 25, 2026

QUININE Drug Patent Profile

Name: QUININE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Quinine, and what generic alternatives are available?

Quinine is a drug marketed by Amneal Pharms, Aurobindo Pharma Usa, Lupin, Novast Labs, and Teva Pharms. and is included in five NDAs.

The generic ingredient in QUININE is quinine sulfate. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Quinine

A generic version of QUININE was approved as quinine sulfate by TEVA PHARMS on September 28^th, 2012.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for QUININE?
What are the global sales for QUININE?
What is Average Wholesale Price for QUININE?

Summary for QUININE

US Patents:	0
Applicants:	5
NDAs:	5
Drug Prices:	Drug price information for QUININE
DailyMed Link:	QUININE at DailyMed

Drug patent expirations by year for QUININE

US Patents and Regulatory Information for QUININE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms	QUININE SULFATE	quinine sulfate	CAPSULE;ORAL	203729-001	Jul 15, 2015	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Novast Labs	QUININE SULFATE	quinine sulfate	CAPSULE;ORAL	204372-001	Jul 22, 2015	AB	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo Pharma Usa	QUININE SULFATE	quinine sulfate	CAPSULE;ORAL	202581-001	Dec 14, 2012		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.